Topics of Interest

Filter

Early Communication About Safety of Lantus (insulin glargine)

الأدوية الجلدية المستخدمة للتخدير الموضعي وتأثيراتها الجانبية المهددة للحياة

Proton-Pump Inhibitor Therapy Induces Acid-Related Symptoms in Healthy Volunteers After Withdrawal of Therapy

Diabetes drug Avandia comes under new criticism

انخفاض عدد كريات الدم الحمراء أحد عوامل الخطر في وفاة المسنين

تحديث معلومات السلامة الدوائية الخاصة بعقار انسولين قلارجين (Insulin glargine, Lantus®)

Increased Risk of Lymphoma and Other Cancers Associated With the Use of Tumor Necrosis Factor (TNF) Blockers(marketed as Remicade, Enbrel, Humira, Cimzia, and Simponi)

Information for Healthcare Professionals: OnabotulinumtoxinA (marketed as Botox/Botox Cosmetic),

Early Communication about an Ongoing Safety Review of Orlistat

Previous page
First page
…
8
9
10
11
…
Last page
Next page

An official government website affiliated with the Government of the Kingdom of Saudi Arabia.

Official Saudi government website domains end with gov.sa

Government websites use the protocol. HTTPS for encryption and security.

Registered with the Digital Government Authority under number:

Suggestions